![Daniel Tassé](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 345 755 $ al 30/06/2026
Daniel Tassé is Chief Executive Officer & Director at DBV Technologies SA since 2019, Director at BioQ Pharma, Inc. since 2014, Lead Independent Non-Executive Director at REGENXBIO, Inc. since 2024, and Director at Roundtable On Critical Care Policy.
Former roles include Chairman, President & Chief Executive Officer at Ikaria, Inc. from 2009 to 2015; Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc. from 2016 to 2018; Director at Biotechnology Innovation Organization from 2011 to 2015; Director at Bellerophon Therapeutics, Inc. from 2014 to 2019; Senior Independent Director at Indivior Ltd. from 2020 to 2021; Vice President & Regional Director-Australasia at GSK Plc in 2004; Director at Pharmaceutical Research & Manufacturers of America from 2011 to 2015; Independent Director at HLS Therapeutics, Inc. from 2018 to 2019; GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc. in 2008; Member at Healthcare Leadership Council; and Chief Financial Officer at NRG Energy Ltd. Education includes undergraduate studies at the University of Montréal.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REGENXBIO, INC. 0,06 % | 29/05/2026 | 28.861 ( 0,06 % ) | 345 755 $ | 30/06/2026 |
DBV TECHNOLOGIES SA -.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REGENXBIO INC. | Director/Miembro de la Junta | 15/08/2016 |
| DBV TECHNOLOGIES | Director Ejecutivo | 29/11/2018 |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Medical SpecialtiesHealth Technology Designs and develops drug delivery systems for healthcare community | Director/Miembro de la Junta | 01/12/2014 |
Roundtable On Critical Care Policy | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Presidente | 19/11/2020 |
| BELLEROPHON THERAPEUTICS, INC. | Director Ejecutivo | 01/06/2014 |
| HLS THERAPEUTICS INC. | Director/Miembro de la Junta | 01/03/2019 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Director Ejecutivo | 01/11/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Miembro de la Junta | 01/06/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Medical SpecialtiesHealth Technology Designs and develops drug delivery systems for healthcare community | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
NRG Energy Ltd.
 NRG Energy Ltd. Food RetailRetail Trade Retails food products | Retail Trade |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Roundtable On Critical Care Policy | |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
